22 May 2013
Keywords: valeant, appoints, gsk, steve, stefano, its, board
Article | 02 April 2009
USA-based Valeant Pharmaceuticals has appointed GlaxoSmithKline senior vice president Steve Stefano to its board of directors for a term
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 April 2009
21 May 2013
© 2013 thepharmaletter.com